VaxigripTetra Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Quadrivalent flu vaccine (split virion, inactivated)

Indications/Uses

Active immunisation of adults, pregnant women & childn from 6 mth for prevention of flu disease caused by 2 influenza A virus subtypes & 2 influenza B virus types. Passive protection of infants <6 mth & born to women vaccinated during pregnancy.

Click to view VaxigripTetra detailed prescribing information

Dosage/Direction for Use

IM/SC Adult, pregnant women & childn 6 mth-17 yr 1 dose of 0.5 mL. Childn <9 yr who have not been previously vaccinated 2nd dose of 0.5 mL given after at least 4 wk interval.

Click to view VaxigripTetra detailed prescribing information

Overdosage

View VaxigripTetra overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to vaccine, eggs (ovalbumin, chicken proteins), neomycin, formaldehyde, octoxinol-9. Postpone vaccination in moderate or severe febrile or acute disease.

Click to view VaxigripTetra detailed prescribing information

Special Precautions

Anaphylactic reaction. Not to be inj intravascularly. Thrombocytopaenia or bleeding disorder; syncope. Insufficient Ab response in patients w/ endogenous or iatrogenic immunosuppression. Interference w/ serological testing. Infants <6 mth.

Click to view VaxigripTetra detailed prescribing information

Use In Pregnancy & Lactation

Click to view VaxigripTetra detailed prescribing information

Adverse Reactions

Headache; myalgia; malaise, shivering, fever, inj site pain, erythema, swelling & induration. Childn: Vomiting; irritability, lost appetite, abnormal crying, drowsiness, inj site tenderness. Inj site ecchymosis.

Click to view VaxigripTetra detailed prescribing information

Drug Interactions

Reduced immunological response w/ immunosuppressant treatment. False +ve results in serology tests using ELISA method.

Click to view VaxigripTetra detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view VaxigripTetra detailed prescribing information

Storage

View VaxigripTetra storage conditions for details to ensure optimal shelf-life.

Description

View VaxigripTetra description for details of the chemical structure and excipients (inactive components).

Action

View VaxigripTetra mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the class of influenza viral vaccines.

Regulatory Classification

Presentation/Packing

Form

VaxigripTetra vaccine (inj) (pre-filled syringe) 0.5 mL/dose

Packing/Price

1's

VaxigripTetra

vaccine, influenza

Manufacturer:

sanofi pasteur

Distributor:

Zuellig Pharma